On Tuesday, Following U.S. Stocks were among the “Top Gainers”: Cempra, (NASDAQ:CEMP), GoPro, (NASDAQ:GPRO), Ascena Retail Group, (NASDAQ:ASNA)

• Cempra, Inc. (NASDAQ:CEMP), with shares inclined 2.34%, closed at $35.37, hitting new 52-week high of $36.63.
• GoPro, Inc. (NASDAQ:GPRO), with shares climbed 2.06%, settled at $38.73.
• Ascena Retail Group Inc. (NASDAQ:ASNA), with shares surged 2.01%, and closed at $13.69.

Latest NEWS regarding these Stocks are depicted underneath:

Cempra, Inc. (NASDAQ:CEMP)

Formerly on February 25, Cempra, Inc. (CEMP), a clinical-stage pharmaceutical corporation focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, stated financial results for the quarter and year ended December 31, 2014 and offered an update on recent corporate developments.

Fourth Quarter 2014 and Recent Corporate Highlights:

• In November 2014, Cempra received authorization for the next phase of its existing contract with the Biomedical Advanced Research and Development Authority (BARDA). The authorization will make accessible funding of $16.0 million for two clinical studies of solithromycin in pediatric patients aged newborn to 17 years. Subjects enrolled in the study may receive intravenous, oral suspension or oral capsule formulations of solithromycin.
• On December 18, 2014, Cempra’s administration met with the FDA to talk about the U.S. regulatory pathway for Taksta(TM). The outcome from this positive meeting is that Cempra has begun planning a Phase 3 registration trial in refractory bone and joint infection. At the FDA’s suggestion, the clinical program will be augmented with a Phase 3 trial in acute bacterial skin and skin structure infection (ABSSSI).
• In January 2015, the corporation stated positive topline results from Solitaire-Oral, a global, pivotal Phase 3 clinical trial of solithromycin oral capsules in community attaind bacterial pneumonia (CABP). Solithromycin met the primary objective of statistical non-inferiority of the early clinical response at 72 hours after initiation of therapy contrast to moxifloxacin in the intent-to-treat (ITT) population. Solithromycin also met the secondary objectives of non-inferiority in clinical success at the short term follow up visit, 5-10 days after the end of therapy in the ITT, mITT (ITT population with microbial isolates) and clinically evaluable populations. The corporation plans to present additional data from the Solitaire-Oral study at forthcoming scientific meetings.
• Cempra accomplished a public offering of 6,037,500 shares of ordinary stock in January 2015 at $24.50 per share, inclusive of the full exercise by the underwriters to purchase additional shares at the public offering price. Net proceeds from the offering totaled $138.7 million after underwriting discounts and commissions and other offering expenses.

Cempra, Inc., a clinical-stage pharmaceutical corporation, focuses on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases in North America. Its lead product candidates comprise solithromycin (CEM-101), which is in Phase III clinical trials for the treatment of community attaind bacterial pneumonia, in addition to for uncomplicated bacterial urethritis; and Taksta (CEM-102), an antibiotic that has accomplished Phase II clinical trials for refractory bone and joint infections.

GoPro, Inc. (NASDAQ:GPRO)

Formerly on March 2, GoPro, Inc. (GPRO), enabler of some of today’s most engaging content, declared the launch of the Done in One campaign, offering musicians an opportunity to capture their best GoPro musical moment in one take. This ongoing multi-tiered national campaign is co-presented by Guitar Center and GoPro. Contestants will submit their best raw GoPro music clip for a chance to win career supporting prize packages from Guitar Center, GoPro and participating musical instrument partners.

How to Enter:

Musicians nationwide are encouraged to upload their best-unedited GoPro music moment, captured with a GoPro camera, to the official Done in One website: http://www.guitarcenter.com/doneinone. Judges will review artist’s submissions based on cinematography and perspective, creativity and originality, sound and lighting and performance and style. After GoPro approves and selects the top raw clips, the team will post the content to the official Done in One contest website (see contest website for full details). One winning video will be selected each month to receive the monthly prize pack and one Grand prize winner will be selected after 5 months to receive the ultimate prize pack.

GoPro, Inc. develops hardware and software solutions to alleviate consumer pain points associated with capturing, managing, sharing, and enjoying engaging content.

Ascena Retail Group Inc. (NASDAQ:ASNA)

Lane Bryant is a wholly-owned partner of Ascena Retail Group, Inc. (ASNA).

Lane Bryant, the nation’s leading women’s special size apparel retailer, is excited to declare the Grand Opening of the brand’s newest location at Belmar in Lakewood, CO.

Where: Belmar, 340 South Teller Street, Lakewood, CO 80226

When: March 13-15, 2015.

Ascena Retail Group, Inc., through its auxiliaries, operates as a specialty retailer of apparel for women, and tween girls and boys. It operates through five segments: Justice, Lane Bryant, maurices, dressbarn, and Catherines segments.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content described in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.